| LEMS | Lambert Eaton Myasthenic Syndrome |
|---|---|
| OHA | Oral Hypoglycemic Agents |
| CTA | Canadian Tuberculosis Association; chemotactic activity; chromotropic acid; Committee on Thrombolyti... |
| ELS | Eaton-Lambert syndrome; electron loss spectroscopy; extended least square; extracorporeal life suppo... |
| ICAAC | Interscience Conference on Antimicrobial Agents and Chemotherapy |
| LEMS | Lambert--Eaton myasthenic syndrome |
|---|---|
| LES | Lambert-Eaton myasthenic syndrome |
| CWA | Chemical warfare agents |
| DBA | Dentin bonding agents |
| NSAID | non steroidal anti-inflammatory agents |
| Eaton agent | A small atypical form of bacteria, intermediate in size between typical bacteria and viruses. Thought to play a significant role in pneumonia and bronchitis. Mycoplasmal respiratory infections are common in children and young adults. Common symptoms include malaise, fever, chills and a dry hacking cough. (27 Sep 1997) |
|---|---|
| Eaton agent pneumonia | An acute systemic disease with involvement of the lungs, caused by Mycoplasma pneumoniae and marked by high fever, cough, relatively few physical signs, and scattered densities on X-rays; usually associated with development of cold agglutinins and antibodies to the bacteria. Synonym: atypical pneumonia, Eaton agent pneumonia, mycoplasmal pneumonia. (05 Mar 2000) |
| eaton-lambert syndrome | <radiology> Myasthenia, bronchial carcinoma, often small cell carcinoma (12 Dec 1998) |
| Eaton, Lee | <person> U.S. Neurologist, 1905-1958. See: Eaton-Lambert syndrome. (05 Mar 2000) |
| Eaton, Monroe | <person> U.S. Microbiologist, *1904. See: Eaton agent, Eaton agent pneumonia. (05 Mar 2000) |
| lambert-eaton myasthenic syndrome | <neurology> An acquired autoimmune disease characterised by weakness and fatigability of proximal muscles, particularly of the pelvic girdle and thighs, with relative sparing of extraocular and bulbar muscles. It is often associated with small cell carcinoma of the lung. The neuromuscular defect in this disease is believed to be due to a deficient release of acetylcholine. (08 Mar 2000) |
| Lambert-Eaton syndrome | <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness. (27 Sep 1997) |
| abortifacient agents | Chemical substances that interrupt pregnancy after implantation. (12 Dec 1998) |
| abortifacient agents, non-steroidal | Non-steroidal chemical compounds with abortifacient activity. (12 Dec 1998) |
| abortifacient agents, steroidal | Steroidal compounds with abortifacient activity. (12 Dec 1998) |
| adrenergic agents | Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (12 Dec 1998) |
| alkylating agents | Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agent, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (12 Dec 1998) |
| anti-allergic agents | Agents that are used to treat allergic reactions. most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (12 Dec 1998) |
| anti-allergic and respiratory system agents | A collective term for drugs used to treat allergic reactions as well as those drugs that produce an effect on the respiratory system. (12 Dec 1998) |
| anti-anxiety agents | Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anaesthesia adjuvants. Adrenergic beta-antagonists are commonly used in the symptomatic treatment of anxiety but are not included here. Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anaesthesia adjuvants. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|